F
Frank A. Post
Researcher at University of Cambridge
Publications - 249
Citations - 9502
Frank A. Post is an academic researcher from University of Cambridge. The author has contributed to research in topics: Kidney disease & Medicine. The author has an hindex of 45, co-authored 228 publications receiving 7746 citations. Previous affiliations of Frank A. Post include University of London & Rockefeller University.
Papers
More filters
Journal ArticleDOI
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Paul E. Sax,David A. Wohl,Michael Yin,Frank A. Post,Edwin DeJesus,Michael S. Saag,Anton Pozniak,Melanie Thompson,Daniel Podzamczer,Jean-Michel Molina,Shinichi Oka,Ellen Koenig,Benoit Trottier,Jaime Andrade-Villanueva,Gordon Crofoot,Joseph M. Custodio,Andrew Plummer,Lijie Zhong,Huyen Cao,Hal Martin,Christian Callebaut,Andrew K. Cheng,Marshall W. Fordyce,Scott McCallister +23 more
TL;DR: Renal and bone effects were significantly reduced in patients given E/C/F/tenofovir alafenamide or E-C-F-tenofavir disoproxil fumarate and the main outcomes were the proportion of patients with plasma HIV-1 RNA less than 50 copies per mL at week 48 as defined by the US Food and Drug Adminstration snapshot algorithm and pre-specified renal and bone endpoints at 48 weeks.
Journal ArticleDOI
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
Margaret T May,Mark Gompels,Valerie Delpech,Kholoud Porter,Chloe Orkin,Stephen Kegg,Phillip Hay,Margaret Johnson,Adrian Palfreeman,Richard Gilson,David R. Chadwick,Fabiola Martin,Teresa Hill,John Walsh,Frank A. Post,Martin Fisher,Jonathan Ainsworth,Sophie Jose,Clifford Leen,Mark Nelson,Jane Anderson,Caroline A. Sabin +21 more
TL;DR: Patients who started ART with a low CD4+ cell count significantly improve their life expectancy if they have a good CD4- cell count response and undetectable viral load.
Journal ArticleDOI
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012
Ian Williams,Duncan Churchill,Jane Anderson,Marta Boffito,Mark Bower,Gus Cairns,Kate Cwynarski,Simon Edwards,Sarah Fidler,Martin Fisher,Andrew Freedman,Anna Maria Geretti,Yvonne Gilleece,Rob Horne,Margaret Johnson,Saye Khoo,Clifford Leen,Clifford Leen,Neal Marshall,Mark T. Nelson,Chloe Orkin,Nicholas I. Paton,Andrew N. Phillips,Frank A. Post,Frank A. Post,Anton Pozniak,Caroline A. Sabin,Roy Trevelion,Andrew Ustianowski,John Walsh,Laura Waters,Edmund Wilkins,Alan Winston,Alan Winston,M Youle +34 more
TL;DR: These guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection and at community advocates responsible for promoting the best interests and care of HIV-positive adults.
Journal ArticleDOI
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
Amanda Mocroft,Jens D Lundgren,Jens D Lundgren,Miriam Lewis Sabin,Antonella d'Arminio Monforte,Norbert H. Brockmeyer,Jordi Casabona,Antonella Castagna,Dominique Costagliola,Dominique Costagliola,François Dabis,François Dabis,Stéphane De Wit,Gerd Fätkenheuer,Hansjakob Furrer,Anne A.M. Johnson,Marios M.K. Lazanas,Catherine Leport,Catherine Leport,Santiago Moreno,Niels Obel,Frank A. Post,Joanne Reekie,Joanne Reekie,Peter Reiss,Caroline A. Sabin,Adriane Skaletz-Rorowski,Ignacio Suárez-Lozano,Carlo Torti,Josiane Warszawski,Robert Zangerle,Céline Fabre-Colin,Céline Fabre-Colin,Jesper Kjaer,Geneviève Chêne,Geneviève Chêne,Jesper Grarup,Ole Kirk,Ole Kirk +38 more
TL;DR: Amanda Mocroft and colleagues investigate risk factors and health outcomes associated with diagnosis at a late stage of infection in individuals across Europe.
Journal ArticleDOI
Mycobacterium tuberculosis Growth at the Cavity Surface: a Microenvironment with Failed Immunity
Gilla Kaplan,Frank A. Post,Andre L. Moreira,Helen Wainwright,Barry N. Kreiswirth,Melike Tanverdi,Barun Mathema,Srinivas V. Ramaswamy,Gabi Walther,Lafras M. Steyn,Clifton E. Barry,Linda-Gail Bekker +11 more
TL;DR: The mutation profile of the isolates suggested that a single founder strain of Mycobacterium tuberculosis may undergo genetic changes during treatment, leading to acquisition of additional drug resistance independently in discrete physical locales.